{"organizations": [], "uuid": "f38f70bf95beb514b08397ad35818de76968c52b", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews\r", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-allergan-ironwood-announce-settlem/brief-allergan-ironwood-announce-settlement-with-sun-pharma-idUSFWN1PB0UA", "country": "US", "domain_rank": 408, "title": "BRIEF-Allergan, Ironwood Announce Settlement With Sun Pharma", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-01-16T17:42:00.000+02:00", "replies_count": 0, "uuid": "f38f70bf95beb514b08397ad35818de76968c52b"}, "author": "", "url": "https://www.reuters.com/article/brief-allergan-ironwood-announce-settlem/brief-allergan-ironwood-announce-settlement-with-sun-pharma-idUSFWN1PB0UA", "ord_in_thread": 0, "title": "BRIEF-Allergan, Ironwood Announce Settlement With Sun Pharma", "locations": [], "entities": {"persons": [], "locations": [{"name": "u.s.", "sentiment": "none"}], "organizations": [{"name": "ironwood announce settlement with sun pharma", "sentiment": "negative"}, {"name": "allergan plc", "sentiment": "none"}, {"name": "sun pharma reuters", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}, {"name": "allergan", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Jan 16 (Reuters) - Allergan Plc:\n* IRONWOOD AND ALLERGAN ANNOUNCE SETTLEMENT WITH SUN PHARMA RESOLVING LINZESS® (LINACLOTIDE) PATENT LITIGATION\n* SAYS PER SETTLEMENT TERMS, IRONWOOD, CO TO GRANT UNITS OF SUN PHARMA LICENSE TO MARKET GENERIC VERSION OF LINZESS IN U.S. BEGINNING FEB 1, 2031​\n* SAYS ‍ADDITIONAL DETAILS REGARDING SETTLEMENT WERE NOT DISCLOSED​\n* SAYS IRONWOOD PHARMACEUTICALS, CO ANNOUNCED COMPANIES REACHED AN AGREEMENT WITH WHOLLY-OWNED UNITS OF SUN PHARMACEUTICAL INDUSTRIES\n* SAYS ‍AS A RESULT OF SETTLEMENT, ALL HATCH-WAXMAN LITIGATION BETWEEN COMPANIES AND SUN PHARMA REGARDING LINZESS PATENTS TO BE DISMISSED​ Source text for Eikon: Further company coverage:\n ", "external_links": [], "published": "2018-01-16T17:42:00.000+02:00", "crawled": "2018-01-16T18:02:54.023+02:00", "highlightTitle": ""}